Researchers urge delay in administering Pfizer vaccine's second dose, cite strong data

By Reuters | Feb. 18, 2021

**Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo.** [Reuters]

Researchers on Wednesday urged governments to delay administering the second dose of Pfizer Inc’s COVID-19 vaccine, which they said had an efficacy of 92.6% after the first dose.

Premium Article

Get Full Access for Ksh299/Week.

Bold Reporting Takes Time, Courage and Investment. Stand With Us.

Continue Reading →

What you get

Unlimited access to all premium content
Ad-free browsing experience
Mobile-optimised reading
Weekly newsletters & digests

Pay via

M - PESA

VISA

Airtel Money

Secure Payments Kenya's most trusted newsroom since 1902

Support Independent Journalism

Journalism can't be free because the truth demands investment. At The Standard, we invest time, courage and skills to bring you accurate, factual and impactful stories. Subscribe today and stand with us in the pursuit of credible journalism.

Pay via

M - PESA

VISA

Airtel Money

Secure Payment Kenya's most trusted newsroom since 1902

Follow The Standard on Google News

Researchers urge delay in administering Pfizer vaccine's second dose, cite strong data

Get Full Access for Ksh299/Week.

Stand With Bold Journalism.
Stand With The Standard.

Related Topics

Popular this week

Latest Stories

The Standard Insider

Digger Classified

GET OUR NEWSLETTER

CONNECT WITH US

FOR THE LATEST JOB ADVERTS

DIGGER JOBS

Digger Motors

Digger Real Estate

Researchers urge delay in administering Pfizer vaccine's second dose, cite strong data

Get Full Access for Ksh299/Week.

Stand With Bold Journalism. Stand With The Standard.

Related Topics

Trending Now

Popular this week

Latest Stories

The Standard Insider

Digger Classified

GET OUR NEWSLETTER

CONNECT WITH US

FOR THE LATEST JOB ADVERTS

Stand With Bold Journalism.
Stand With The Standard.